(E)-3-(4-(Trifluoromethyl)phenyl)-N-(((2R,3S,4R,5S)-3,4,5-trihydroxypiperidin-2-yl)methyl)acrylamide

ID: ALA4168689

Chembl Id: CHEMBL4168689

PubChem CID: 145956209

Max Phase: Preclinical

Molecular Formula: C16H19F3N2O4

Molecular Weight: 360.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(/C=C/c1ccc(C(F)(F)F)cc1)NC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C16H19F3N2O4/c17-16(18,19)10-4-1-9(2-5-10)3-6-13(23)21-7-11-14(24)15(25)12(22)8-20-11/h1-6,11-12,14-15,20,22,24-25H,7-8H2,(H,21,23)/b6-3+/t11-,12+,14+,15-/m1/s1

Standard InChI Key:  ZVPFOBWIGFRKAS-OXMRTWMISA-N

Alternative Forms

  1. Parent:

    ALA4168689

    ---

Associated Targets(Human)

GLA Tclin Alpha-galactosidase A (5444 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GAA Tclin Lysosomal alpha-glucosidase (35701 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLB1 Tchem Beta-galactosidase (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAN2B1 Tchem Lysosomal alpha-mannosidase (172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lymphocyte (105 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Alpha-glucosidase (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alpha-galactosidase (362 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.33Molecular Weight (Monoisotopic): 360.1297AlogP: -0.11#Rotatable Bonds: 4
Polar Surface Area: 101.82Molecular Species: NEUTRALHBA: 5HBD: 5
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.91CX Basic pKa: 7.85CX LogP: 0.06CX LogD: -0.52
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.48Np Likeness Score: 0.34

References

1. Li HY, Lee JD, Chen CW, Sun YC, Cheng WC..  (2018)  Synthesis of (3S,4S,5S)-trihydroxylpiperidine derivatives as enzyme stabilizers to improve therapeutic enzyme activity in Fabry patient cell lines.,  144  [PMID:29289886] [10.1016/j.ejmech.2017.12.036]

Source